| Item Type | Name |
|
Concept
|
Pathology, Clinical
|
|
Concept
|
Research Personnel
|
|
Concept
|
Research Support as Topic
|
|
Concept
|
Research
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Peer Review, Research
|
|
Concept
|
Decision Support Systems, Clinical
|
|
Concept
|
Research Design
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Clinical Medicine
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Comparative Effectiveness Research
|
|
Concept
|
Ethics Committees, Research
|
|
Concept
|
Qualitative Research
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Health Services Research
|
|
Concept
|
Research Subjects
|
|
Concept
|
Research Report
|
|
Academic Article
|
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis.
|
|
Academic Article
|
Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
|
|
Academic Article
|
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion.
|
|
Academic Article
|
Adjuvant therapy of colon cancer.
|
|
Academic Article
|
Adjuvant therapy for colorectal cancer.
|
|
Academic Article
|
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071).
|
|
Academic Article
|
Biochemical and clinical pharmacology of 5-fluorouracil.
|
|
Academic Article
|
Antifolates: the next generation.
|
|
Academic Article
|
Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.
|
|
Academic Article
|
End points in cancer clinical trials and the drug approval process.
|
|
Academic Article
|
Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.
|
|
Academic Article
|
Laboratory and clinical studies of biochemical modulation by hydroxyurea.
|
|
Academic Article
|
Pharmacology and clinical status of capecitabine.
|
|
Academic Article
|
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer.
|
|
Academic Article
|
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
|
|
Academic Article
|
Tumor markers as clinical cancer tests--are we there yet?
|
|
Academic Article
|
Oral fluoropyrimidine treatment of colorectal cancer.
|
|
Academic Article
|
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
|
|
Academic Article
|
Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs.
|
|
Academic Article
|
Cetuximab in the treatment of colorectal cancer.
|
|
Academic Article
|
A concise history of the cancer and leukemia group B.
|
|
Academic Article
|
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
|
|
Academic Article
|
The role of cooperative groups in cancer clinical trials.
|
|
Academic Article
|
Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer.
|
|
Academic Article
|
3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.
|
|
Academic Article
|
American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
|
|
Academic Article
|
Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
|
|
Academic Article
|
The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics).
|
|
Academic Article
|
Introduction: contributions of the cooperative groups.
|
|
Academic Article
|
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.
|
|
Academic Article
|
First-line treatment options for patients with metastatic colorectal cancer.
|
|
Academic Article
|
Are targeted therapies really targeted?
|
|
Academic Article
|
Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
|
|
Academic Article
|
The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
|
|
Academic Article
|
Translating the cancer genome into clinically useful tools and strategies.
|
|
Academic Article
|
Refocusing the war on cancer: the critical role of personalized treatment.
|
|
Academic Article
|
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indications.
|
|
Academic Article
|
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
|
|
Academic Article
|
FDG-PET lymphoma demonstration project invitational workshop.
|
|
Academic Article
|
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
|
|
Academic Article
|
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.
|
|
Academic Article
|
Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.
|
|
Academic Article
|
WIN Consortium--challenges and advances.
|
|
Academic Article
|
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
|
|
Academic Article
|
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.
|
|
Academic Article
|
Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
|
|
Academic Article
|
Clinical trials in the era of personalized oncology.
|
|
Academic Article
|
Development and use of integral assays in clinical trials.
|
|
Academic Article
|
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
|
|
Academic Article
|
Accrual to cancer clinical trials in the era of molecular medicine.
|
|
Academic Article
|
Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.
|
|
Academic Article
|
Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
|
|
Academic Article
|
Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.
|
|
Academic Article
|
Prognostic factors for survival in patients treated in phase I clinical trials.
|
|
Academic Article
|
Data submission standards and evidence requirements.
|
|
Academic Article
|
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
|
|
Academic Article
|
Clinical implications of tumor heterogeneity.
|
|
Academic Article
|
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
|
|
Academic Article
|
Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.
|
|
Academic Article
|
Tumor cell heterogeneity: implications for clinical practice.
|
|
Academic Article
|
Using patient-initiated study participation in the development of evidence for personalized cancer therapy.
|
|
Academic Article
|
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
|
|
Academic Article
|
Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.
|
|
Academic Article
|
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
|
|
Academic Article
|
Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial.
|
|
Academic Article
|
Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
|
|
Academic Article
|
Clinical pharmacology of methotrexate.
|
|
Academic Article
|
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
|
|
Academic Article
|
The next phase of chemoprevention research.
|
|
Academic Article
|
Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
|
|
Academic Article
|
Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.
|
|
Academic Article
|
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
|
|
Academic Article
|
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
|
|
Academic Article
|
Target practice: oncology drug development in the era of genomic medicine.
|
|
Academic Article
|
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.
|
|
Academic Article
|
An accelerated pathway for targeted cancer therapies.
|
|
Academic Article
|
Role of randomized phase III trials in an era of effective targeted therapies.
|
|
Academic Article
|
Randomized controlled trials and comparative effectiveness research.
|
|
Academic Article
|
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.
|
|
Academic Article
|
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
|
|
Academic Article
|
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
|
|
Academic Article
|
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
|
|
Academic Article
|
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
|
|
Academic Article
|
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
|
|
Academic Article
|
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
|
|
Academic Article
|
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.
|
|
Academic Article
|
Breaking a vicious cycle.
|
|
Academic Article
|
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
|
|
Academic Article
|
Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.
|
|
Academic Article
|
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis.
|
|
Academic Article
|
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
|
|
Academic Article
|
Advanced clinical trials for China.
|
|
Academic Article
|
Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
|
|
Academic Article
|
Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement.
|
|
Academic Article
|
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.
|
|
Academic Article
|
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
|
|
Academic Article
|
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
|
|
Academic Article
|
Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.
|
|
Academic Article
|
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
|
|
Academic Article
|
Publicly funded clinical trials and the future of cancer care.
|
|
Academic Article
|
Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
|
|
Academic Article
|
Innovative clinical trials for development of personalized cancer medicine.
|
|
Academic Article
|
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.
|
|
Academic Article
|
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
|
|
Academic Article
|
Integrating biomarkers in colorectal cancer trials in the West and China.
|
|
Academic Article
|
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.
|
|
Academic Article
|
American Society of Clinical Oncology 2013 top five list in oncology.
|
|
Academic Article
|
Wither the cooperative groups?
|
|
Academic Article
|
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.
|
|
Academic Article
|
The evidence framework for precision cancer medicine.
|
|
Academic Article
|
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
|
|
Academic Article
|
Reply to F.E. Vera-Badillo et al.
|
|
Academic Article
|
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement.
|
|
Academic Article
|
Accelerating anticancer drug development - opportunities and trade-offs.
|
|
Academic Article
|
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
|
|
Academic Article
|
American Society of Clinical Oncology Statement: Biosimilars in Oncology.
|
|
Academic Article
|
Modernizing Eligibility Criteria for Molecularly Driven Trials.
|
|
Academic Article
|
Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.
|
|
Academic Article
|
Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.
|
|
Academic Article
|
Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise.
|
|
Academic Article
|
The promise of Immuno-oncology: implications for defining the value of cancer treatment.
|
|
Academic Article
|
Challenges and approaches to implementing master/basket trials in oncology.
|
|
Academic Article
|
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.
|
|
Academic Article
|
Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology.
|
|
Academic Article
|
Discrepancies in Financial Self-Disclosures and Open Payments Reporting Among Authors of Clinical Oncology Research Studies.
|
|
Academic Article
|
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
|
|
Academic Article
|
The International Collaboration for Cancer Classification and Research.
|
|
Academic Article
|
Progress in Cancer Research, Prevention, and Care.
|
|
Academic Article
|
The National Clinical Trials Network and the cooperative groups: The road not taken.
|
|
Academic Article
|
Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
|
|
Academic Article
|
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
|
|
Academic Article
|
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.
|
|
Academic Article
|
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
|
|
Academic Article
|
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
|
|
Academic Article
|
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations.
|
|
Academic Article
|
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
|
|
Academic Article
|
The Porto European Cancer Research Summit 2021.
|
|
Academic Article
|
Beyond the COVID-19 Pandemic: Sustaining and Improving Equitable Cancer Care and Research.
|
|
Concept
|
Clinical Decision-Making
|
|
Grant
|
Cancer and Leukemia Group B
|
|
Grant
|
Cancer and Leukemia Group B Human Specimen Repositories
|
|
Grant
|
Cancer and Leukemia Group B CCOP Research Base
|
|
Grant
|
CELLULAR PHARMACOLOGY OF THE STEREOISOMERS OF LEUCOVORIN
|
|
Academic Article
|
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
|
|
Academic Article
|
The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial.
|